Oct. 15 – Supreme Court Series: Teva Pharmaceuticals USA v. Sandoz

 

October 15, 2014 | 4:00pm | Room 603
American University Washington College of Law
Registration | Logistics and Directions

In PIJIP’s ongoing Supreme Court Series, a panel of counsel for amici and parties will discuss the case on the afternoon following oral argument before the Court. The live webcast will be available once the event begins.

Panel:

  • Prof. Michael Carroll, American University Washington College of Law
  • Matthew HoffmanPartner Goodwin Procter
  • Suzanne MichelSenior Patent Counsel, Google, Inc.
  • Prof. Jonas Anderson, American University Washington College of Law

Issue:

Whether a district court’s factual finding in support of its construction of a patent claim term may be reviewed de novo, as the Federal Circuit requires (and as the panel explicitly did in this case), or only for clear error, as Federal Rule of Civil Procedure 52(a) requires.

Transcript of Oral Argument

Briefs:

Brief of petitioners Teva Pharmaceuticals USA, Inc., et al.
Brief of respondents Sandoz, Inc., et al.

Amicus Briefs:

Brief amicus curiae of the United States
Brief amicus curiae of Federation Internationale Des Conseils En Propriete Intellectuelle (FICPI)
Brief amici curiae of Professors Peter S. Menell, et al.
Brief amicus curiae of Houston Intellectual Property Law Association
Brief amicus curiae of American Bar Association
Brief amicus curiae of Fresenius Kabi USA, LLC
Brief amicus curiae of American Intellectual Property Law Association
Brief amicus curiae of Intellectual Property Owners Association
Brief amici curiae of Intel Corporation, et al.
Brief amici curiae of Google Inc., et al.

SCOTUSblog Entry: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.